MedTrace Logo

The Use of Bone Growth Stimulators for Osteoarthritis of the Knee.

NCT03476382 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-01-31

No results posted yet for this study

Summary

The hypothesis of this study is that since osteoarthritis of the knee is primarily a bone disease where the joint changes are secondary, and bone growth stimulators function to decrease intraosseous venous congestion and remodel bone, then there is a potential benefit for the treatment of osteoarthritis of the knee with bone growth stimulators.

Conditions

  • Osteo Arthritis Knee

Interventions

DEVICE

Ultrasound Bone Growth Stimulator

Active device emits ultrasound signals.

Sponsors & Collaborators

  • Coastal Carolinas Integrated Medicine

    lead OTHER

Principal Investigators

  • Kenneth Willeford, MD · Coastal Carolinas Integrated Medicine

  • Sierra Willeford · Coastal Carolinas Integrated Medicine

  • Breanna Willeford · Coastal Carolinas Integrated Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-09
Primary Completion
2018-11-15
Completion
2018-11-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03476382 on ClinicalTrials.gov